Recommendations for Screening, Monitoring, Prevention, Prophylaxis and Therapy of Hepatitis B Virus Reactivation in Patients With Haematologic Malignancies and Patients who Underwent Haematologic Stem Cell Transplantation – A Position Paper

This is a clinical practice guideline for patients with hematologic malignancies and/or patients who underwent hematologic stem cell transplantation (HSCT). who are at risk for hepatitis B virus (HBV) infection reactivation. The guideline provides recommendations on HBV screening, monitoring, prophylaxis, treatment and vaccination in these patients. The primary outcome of interest is the prevention of hepatic failure and death caused by HBV reactivation.